New pathogens in the immunocompromised host.

New pathogens in the immunocompromised host. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

New pathogens in the immunocompromised host. Abstract Text:

S H Zinner,

New pathogens in the immunocompromised host. Publishing Authors By Initials

SH Zinner,

For similar hemic and lymphatic diseases: hematologic diseases: leukocyte disorders: leukopenia: agranulocytosis: neutropenia research abstracts see: hemic and lymphatic diseases: hematologic diseases: leukocyte disorders: leukopenia: agranulocytosis: neutropenia research

PUBMED ID PMID:

MEDLINE DATE:

New pathogens in the immunocompromised host. Journal Published:

PUBLICATION TYPE: Review

Journal: Recent results in cancer research. Fortschritte de

VOLUME: 132

Page Numbers: 231-40

Journal Abbreviation: Recent Results Cancer Res.

ISSN: 0080-0015

DAY: 13

MONTH: 02

YEAR: 1993

New pathogens in the immunocompromised host. Information

Number of References: 23

LANGUAGE: eng

NlmUniqueID: 44671

New pathogens in the immunocompromised host. Keywords Mesh Terms:

KEYWORDS: Neutropenia

MESH TERMS: microbiology

Chemical & Substance for Abstract: New pathogens in the immunocompromised host. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for New pathogens in the immunocompromised host.

AFFILIATION: Brown University Division of Infectious Diseases, Roger Williams Medical Center, Rhode Island Hospital Providence 02129.

Country: GERMANY

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Recent Results Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

New pathogens in the immunocompromised host Related Publications

• An Apgar score for surgery.
• Effects of oxybutynin transdermal system on health-related quality of life and safety in men with overactive bladder and prostate conditions.
• Enrichment of fluoroquinolone-resistant Staphylococcus aureus: oscillating ciprofloxacin concentrations simulated at the upper and lower portions of the mutant selection window.
• Images in clinical medicine. Reversal of laryngeal paresis.
• In vitro models for the study of antibiotic activities.
• New pathogens in the immunocompromised host.
• Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC.
• [Not Available.]
• [Not Available.]
• [Not Available.]
• [On regeneration of damaged endothelium after severe and mild trauma.]
• [The tumors of the sinus maxillaris.]